Overview

A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to determine whether BMS068645 is as effective as Adenosine SPECT at detecting blockages in heart arteries, and to determine if it will have fewer side effects
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Adenosine
Criteria
Inclusion Criteria:

- Referral for pharmacologic stress SPECT MPI

- Have suspected Ischemic heart disease

Exclusion Criteria:

- Acute myocardial Infarction, Coronary artery bypass graft, percutaneous coronary
intervention within 30 days of enrollment

- Severe asthma or COPD